Antibody landscape of C57BL/6 mice cured of B78 melanoma via a combined radiation and immunocytokine immunotherapy regimen von Hoefges, Anna, McIlwain, Sean J, Erbe, Amy K, Mathers, Nicholas, Xu, Angie, Melby, Drew, Tetreault, Kaitlin, Le, Trang, Kim, Kyungmann, Pinapati, Richard S, Garcia, Bradley H, Patel, Jigar, Heck, Mackenzie, Feils, Arika S, Tsarovsky, Noah, Hank, Jacquelyn Ann, Morris, Zachary Scott, Ong, Irene M, Sondel, Paul Mark

Volltext

NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy von Wang, Wei, Erbe, Amy K, Hank, Jacquelyn A, Morris, Zachary S, Sondel, Paul M

Volltext

Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome observed in high-risk neuroblastoma von Tony A. Koehn, Lori L. Scardino, Kory L. Alderson, Amy K. Erbe, Kim A. McDowell, Bartosz eGrzywacz, Jacquelyn A. Hank, Paul Mark Sondel

Volltext

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting von Magee, Kara, Marsh, Ian R, Turek, Michelle M, Grudzinski, Joseph, Aluicio-Sarduy, Eduardo, Engle, Jonathan W, Kurzman, Ilene D, Zuleger, Cindy L, Oseid, Elizabeth A, Jaskowiak, Christine, Albertini, Mark R, Esbona, Karla, Bednarz, Bryan, Sondel, Paul M, Weichert, Jamey P, Morris, Zachary S, Hernandez, Reinier, Vail, David M

Volltext

Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study von SHUSTERMAN, Suzanne, LONDON, Wendy B, GAN, Jacek, EICKHOFF, Jens, DESANTES, Kenneth B, COHN, Susan L, HECHT, Toby, GADBAW, Brian, REISFELD, Ralph A, MARIS, John M, SONDEL, Paul M, GILLIES, Stephen D, HANK, Jacquelyn A, VOSS, Stephan D, SEEGER, Robert C, REYNOLDS, C. Patrick, KIMBALL, Jennifer, ALBERTINI, Mark R, WAGNER, Barrett

Volltext

NK cells propagate T cell immunity following in situ tumor vaccination von Jin, Won Jong, Jagodinsky, Justin C., Vera, Jessica M., Clark, Paul A., Zuleger, Cindy L., Erbe, Amy K., Ong, Irene M., Le, Trang, Tetreault, Kaitlin, Berg, Tracy, Rakhmilevich, Alexander L., Kim, KyungMann, Newton, Michael A., Albertini, Mark R., Sondel, Paul M., Morris, Zachary S.

Volltext

Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group von Hingorani, Pooja, Krailo, Mark, Buxton, Allen, Hutson, Paul, Sondel, Paul M., Diccianni, Mitchell, Yu, Alice, Morris, Carol D., Womer, Richard B., Crompton, Brian, Randall, R Lor, Teot, Lisa A., DuBois, Steven G., Janeway, Katherine A., Gorlick, Richard G., Isakoff, Michael S.

Volltext

A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children's Oncology Gro... von OSENGA, Kaci L, HANK, Jacquelyn A, KRAILO, Mark, ADAMSON, Peter C, REISFELD, Ralph A, GILLIES, Stephen D, SONDEL, Paul M, ALBERTINI, Mark R, GAN, Jacek, STERNBERG, Adam G, EICKHOFF, Jens, SEEGER, Robert C, MATTHAY, Katherine K, REYNOLDS, C. Patrick, TWIST, Clare

Volltext

Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem... von Gilman, Andrew L, Ozkaynak, M Fevzi, Matthay, Katherine K, Krailo, Mark, Yu, Alice L, Gan, Jacek, Sternberg, Adam, Hank, Jacquelyn A, Seeger, Robert, Reaman, Gregory H, Sondel, Paul M

Volltext

Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2 von Yang, Richard K, Kuznetsov, Igor B, Ranheim, Erik A, Wei, Jun S, Sindiri, Sivasish, Gryder, Berkley E, Gangalapudi, Vineela, Song, Young K, Patel, Viharkumar, Hank, Jacquelyn A, Zuleger, Cindy, Erbe, Amy K, Morris, Zachary S, Quale, Renae, Kim, KyungMann, Albertini, Mark R, Khan, Javed, Sondel, Paul M

Volltext

Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma von Albertini, Mark R., Yang, Richard K., Ranheim, Erik A., Hank, Jacquelyn A., Zuleger, Cindy L., Weber, Sharon, Neuman, Heather, Hartig, Greg, Weigel, Tracey, Mahvi, David, Henry, Mary Beth, Quale, Renae, McFarland, Thomas, Gan, Jacek, Carmichael, Lakeesha, Kim, KyungMann, Loibner, Hans, Gillies, Stephen D., Sondel, Paul M.

Volltext

Phase II trial of hu14.18-IL2 for patients with metastatic melanoma von Albertini, Mark R., Hank, Jacquelyn A., Gadbaw, Brian, Kostlevy, Jordan, Haldeman, Jennifer, Schalch, Heidi, Gan, Jacek, Kim, KyungMann, Eickhoff, Jens, Gillies, Stephen D., Sondel, Paul M.

Volltext

Phase I Study of ch 14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Ste... von GILMAN, Andrew L, FEVZI OZKAYNAK, M, SONDEL, Paul M, MATTHAY, Katherine K, KRAILO, Mark, YU, Alice L, GAN, Jacek, STERNBERG, Adam, HANK, Jacquelyn A, SEEGER, Robert, REAMAN, Gregory H

Volltext

Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients von KING, David M, ALBERTINI, Mark R, EICKHOFF, Jens, KENDRA, Kari, REISFELD, Ralph, GILLIES, Stephen D, SONDEL, Paul, SCHALCH, Heidi, HANK, Jacquelyn A, GAN, Jacek, SURFUS, Jean, MAHVI, David, SCHILLER, Joan H, WARNER, Thomas, KIM, Kyungmann

Volltext

Immunogenicity of the Hu14.18-IL2 Immunocytokine Molecule in Adults With Melanoma and Children With Neuroblastoma von Hank, Jacquelyn A, Gan, Jacek, Ryu, Hyunji, Ostendorf, Amy, Stauder, Michael C, Sternberg, Adam, Albertini, Mark, Lo, Kin-Ming, Gillies, Stephen D, Eickhoff, Jens, Sondel, Paul M

Volltext

A Phase I Study of Immunization Using Particle-Mediated Epidermal Delivery of Genes for gp100 and GM-CSF into Uninvolved Skin of Melanoma Patients von CASSADAY, Ryan D, SONDEL, Paul M, HANK, Jacquelyn A, MAHVI, David M, ALBERTINI, Mark R, KING, David M, MACKLIN, Michael D, GAN, Jacek, WARNER, Tom F, ZULEGER, Cindy L, BRIDGES, Alan J, SCHALCH, Heidi G, KYUNG MANN KIM

Volltext

Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma von Albertini, Mark R., Ranheim, Erik A., Zuleger, Cindy L., Sondel, Paul M., Hank, Jacquelyn A., Bridges, Alan, Newton, Michael A., McFarland, Thomas, Collins, Jennifer, Clements, Erin, Henry, Mary Beth, Neuman, Heather B., Weber, Sharon, Whalen, Giles, Galili, Uri

Volltext

Improving Specific Targeting of Tumors Through Bispecific SNIPER Antibodies von Erbe, Amy K, Hernandez, Reinier, Gerhardt, Daniel, Hammer, Bonnie, Felder, Mildred, Bercher, Mark, Dennin, Jennifer, Massey, Christopher, VandenHeuvel, Sabrina, Feils, Arika S, Heck, Mackenzie, Hank, Jacquelyn A, Glasser, Bryan, Green, Roland, Sondel, Paul M

Volltext

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative von Magee, Kara, Marsh, Ian R, Turek, Michelle M, Grudzinski, Joseph, Aluicio-Sarduy, Eduardo, Engle, Jonathan W, Kurzman, Ilene D, Zuleger, Cindy L, Oseid, Elizabeth A, Jaskowiak, Christine, Albertini, Mark R, Esbona, Karla, Bednarz, Bryan, Sondel, Paul M, Weichert, Jamey P, Morris, Zachary S, Hernandez, Reinier, Vail, David M

Volltext

Phase I/II trial of intratumoral administration of hu14.18-IL2, with local radiation, nivolumab, and ipilimumab in subjects with advanced melanoma von Albertini, Mark R., Morris, Zachary Scott, Hank, Jacquelyn A, Ranheim, Erik, Zuleger, Cindy L, McDowell, Kimberly, Quale, Renae M, Monson, Molly, Clements, Erin, Koehn, Tamara, Neuman, Heather B., Weber, Sharon M., Racz, Jennifer, Henry, Mary Beth, Reinstad, Emily, Kim, KyungMann, Gillies, Stephen D., Sondel, Paul M.

Volltext